paperBiotech

Synthesis, biological evaluation & in silico studies of N-(1-aza-2-phenylvinyl)-2-(benzoylamino)-3-phenylprop-2-enamides

Synthesis, biological evaluation & in silico studies of N-(1-aza-2-phenylvinyl)-2-(benzoylamino)-3-phenylprop-2-enamides

publishedDate Venue Letters in Drug Design & Discovery

Source-permitted summary

Synthesis, biological evaluation & in silico studies of N-(1-aza-2-phenylvinyl)-2-(benzoylamino)-3-phenylprop-2-enamides

SourceElsevier BV

Verified by AISci

Public source attached

Source status for this paper in the current AISci reviewed snapshot.

Primary source
Elsevier BV
Correction status
none
Evidence coverage
1 sources / 1 publishers
Last metadata check
Jul 19, 2026
Open primary source

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
Synthesis, biological evaluation & in silico studies of N-(1-aza-2-phenylvinyl)-2-(benzoylamino)-3-phenylprop-2-enamides
Field context
Protein and Drug Design
People and labs
Not stated in the reviewed source.
Why it matters
Recent source-backed research output for AISci Stage A browsing.
Limits to check
AISci rank score does not assess scientific quality or citation impact.

Publication facts

Date
Jul 1, 2026SourceElsevier BV
Venue
Letters in Drug Design & DiscoverySourceElsevier BV
Open access
unknownSourceElsevier BV

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

Topics

Relationship evidence

Timeline

  1. paperSynthesis, biological evaluation & in silico studies of N-(1-aza-2-phenylvinyl)-2-(benzoylamino)-3-phenylprop-2-enamides